Repository of Research and Investigative Information

Repository of Research and Investigative Information

Baqiyatallah University of Medical Sciences

Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinson's and Alzheimer's Diseases

(2018) Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinson's and Alzheimer's Diseases. Current Gene Therapy. pp. 45-63. ISSN 1566-5232

[img] Text
Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinson’s and Alzheimer’s Diseases.pdf

Download (4MB)

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

Brain-Derived Neurotrophic Factor (BDNF) is a dominant neurotrophic factor in the brain which plays a crucial role in differentiation, regeneration and plasticity mechanisms. Binding of the BDNF to its high-affinity Tropomyosin-related kinase B (TrkB) receptor leads to phosphorylation of TrkB, thus activating the three important downstream intracellular signaling cascades within the neural cells including phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT), Phospholipase C-gamma (PLC gamma), and mitogen-activated protein kinase/extracellular signal-related kinase (MAPK/ERK) pathways. Transcription of these pathways is regulated by cAMP Response Element-Binding protein (CREB) transcription factor, which can upregulate gene expression. In this review, we attempted to explore the role of BDNF and its associated pathways in susceptibility to Schizophrenia (Scz), Alzheimer's (AD), and Parkinson's (PD) diseases. Furthermore, we discuss dysfunction in BDNF signaling pathway and the therapeutic potential of BDNF in the treatment of these disorders. The review covers various therapeutic strategies including BDNF gene therapy, transplantation of BDNF-expressing cell grafts, epigenetic manipulation, and intraparenchymal BDNF protein infusion as well. This review seeks to achieve these goals by reviewing recent studies on BDNF and examining the details of BDNF pathway in any of the above-mentioned diseases.

Item Type: Article
Keywords: Gene delivery BDNF PLC gamma MAPK/ERK Susceptibility PI3K/AKT bdnf val66met polymorphism mesenchymal stem-cells activity-dependent secretion messenger-rna expression nerve growth-factor single-nucleotide polymorphisms factor g196a polymorphism marrow stromal cells factor gene protein-kinase Genetics & Heredity
Divisions:
Page Range: pp. 45-63
Journal or Publication Title: Current Gene Therapy
Journal Index: ISI
Volume: 18
Number: 1
Identification Number: https://doi.org/10.2174/1566523218666180302163029
ISSN: 1566-5232
Depositing User: مهندس مهدی شریفی
URI: http://eprints.bmsu.ac.ir/id/eprint/3954

Actions (login required)

View Item View Item